Your browser doesn't support javascript.
Epidemiology of SARS-CoV-2 infection and SARS-CoV-2 positive hospital admissions among children in South Africa.
Kufa, Tendesayi; Jassat, Waasila; Cohen, Cheryl; Tempia, Stefano; Masha, Maureen; Wolter, Nicole; Walaza, Sibongile; von Gottburg, Anne; Govender, Nelesh P; Hunt, Gillian; Shonhiwa, Andronica Moipone; Ebonwu, Joy; Ntshoe, Genevie; Maruma, Wellington; Bapela, Poncho; Ndhlovu, Nomathamsanqa; Mathema, Hlengani; Modise, Motshabi; Shuping, Liliwe; Manana, Pinky N; Moore, David; Dangor, Ziyaad; Verwey, Charl; Madhi, Shabir A; Saloojee, Haroon; Zar, Heather J; Blumberg, Lucille.
  • Kufa T; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
  • Jassat W; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
  • Cohen C; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
  • Tempia S; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
  • Masha M; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
  • Wolter N; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
  • Walaza S; Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • von Gottburg A; MassGenics, Duluth, Georgia, USA.
  • Govender NP; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
  • Hunt G; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
  • Shonhiwa AM; School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Ebonwu J; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
  • Ntshoe G; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
  • Maruma W; School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Bapela P; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
  • Ndhlovu N; School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Mathema H; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
  • Modise M; School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Shuping L; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
  • Manana PN; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
  • Moore D; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
  • Dangor Z; School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
  • Verwey C; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
  • Madhi SA; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
  • Saloojee H; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
  • Zar HJ; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
  • Blumberg L; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Influenza Other Respir Viruses ; 16(1): 34-47, 2022 01.
Article in English | MEDLINE | ID: covidwho-1526373
ABSTRACT

INTRODUCTION:

We describe epidemiology and outcomes of confirmed SARS-CoV-2 infection and positive admissions among children <18 years in South Africa, an upper-middle income setting with high inequality.

METHODS:

Laboratory and hospital COVID-19 surveillance data, 28 January - 19 September 2020 was used. Testing rates were calculated as number of tested for SARS-CoV-2 divided by population at risk; test positivity rates were calculated as positive tests divided by total number of tests. In-hospital case fatality ratio (CFR) was calculated based on hospitalized positive admissions with outcome data who died in-hospital and whose death was judged SARS-CoV-2 related by attending physician.

FINDINGS:

315 570 children aged <18 years were tested for SARS-CoV-2; representing 8.9% of all 3 548 738 tests and 1.6% of all children in the country. Of children tested, 46 137 (14.6%) were positive. Children made up 2.9% (n = 2007) of all SARS-CoV-2 positive admissions to sentinel hospitals. Among children, 47 died (2.6% case-fatality). In-hospital deaths were associated with male sex [adjusted odds ratio (aOR) 2.18 (95% confidence intervals [CI] 1.08-4.40)] vs female; age <1 year [aOR 4.11 (95% CI 1.08-15.54)], age 10-14 years [aOR 4.20 (95% CI1.07-16.44)], age 15-17 years [aOR 4.86 (95% 1.28-18.51)] vs age 1-4 years; admission to a public hospital [aOR 5.07(95% 2.01-12.76)] vs private hospital and ≥1 underlying conditions [aOR 12.09 (95% CI 4.19-34.89)] vs none.

CONCLUSIONS:

Children with underlying conditions were at greater risk of severe SARS-CoV-2 outcomes. Children > 10 years, those in certain provinces and those with underlying conditions should be considered for increased testing and vaccination.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Africa Language: English Journal: Influenza Other Respir Viruses Journal subject: Virology Year: 2022 Document Type: Article Affiliation country: Irv.12916

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Africa Language: English Journal: Influenza Other Respir Viruses Journal subject: Virology Year: 2022 Document Type: Article Affiliation country: Irv.12916